Can Two Successes Outweigh Eleven Failures? FDA Evidence Threshold Is Put Back on the Table
A recent commentary questions the evidence balance behind drug approval through the lens of “two wins and eleven losses”; the real issue is not just the numbers, but how regulators judge the weight of efficacy signals, failed trials, and patient needs.